Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)
Clinical trial NCT01672853 · COMPLETED
Trial details
- NCT number
- NCT01672853
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-04
- Primary completion
- 2016-08-08
- Enrollment
- 235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.